Clinical Trials · NCT00482807

Radiation Therapy, Docetaxel, and Hormone Therapy in High-Risk Locally Advanced Metastasized Prostate Cancer

CompletedPhase 1Gonadorelin (Approved)
Phase
Phase 1
Recruitment status
Completed
Sponsor
University of Nebraska
Enrollment
9
Start date
Aug 2004
Locations
1 site, United States
Primary endpoint
Toxicity rate
View Gonadorelin compound reference